DNA, Genomics Company 23andMe Gets SPAC Deal: What Investors Should Know
Yahoo! Finance
Personalized DNA testing company 23andMe is going public with a SPAC deal announced Thursday. The SPAC Deal: 23andMe is going public with VG Acquisition Corp (NYSE: VGAC), a SPAC from Virgin Group. The deal values 23andMe at $3.5 billion. A $250-million PIPE includes $25-million investments from both Virgin Group’s Richard Branson and Anne Wojcicki, 23andMe's co-founder and CEO. Existing investors in the company include Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), Genentech and Sequoia. Shares of 23...
Continue Reading